Completed PHASE2 INTERVENTIONAL 6-arm NCT02249884

Dose-Response Curve: Interventions to Prevent and Treat Radiodermatitis (DRCPTR)

Use of Chamomilla Recutita Gel and Urea Cream to Prevent and Treat Radiodermatitis: Phase 2 Study

Sponsor: University of Brasilia

Interventions Chamomile Dose A Chamomile Dose B Chamomile Dose C Urea Dose A Urea Dose B Urea Dose C

Updated 6 times since 2017 Last updated: Nov 30, 2015 Started: Feb 28, 2014 Primary completion: Mar 31, 2015 Completion: Nov 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Radiodermatitis, this trial is completed. The trial is conducted by University of Brasilia and has accumulated 6 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Brasilia
University of Washington

Data source: University of Brasilia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brasília, Brazil